Condition: Systemic Lupus Erythematosus · Idiopathic Inflammatory Myopathy · Systemic Sclerosis · Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
The purpose of this study is to establish the tolerability, preliminary efficacy, and pharmacokinetics of CC-97540 in participants with severe, refractory autoimmune diseases (Breakfree-1).
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| University of Colorado Anschutz Medical Campus | Aurora, Colorado, United States | Recruiting |
| Colorado Blood Cancer Institute | Denver, Colorado, United States | Recruiting |
| Local Institution - 0048 | New Haven, Connecticut, United States | Withdrawn |
| Mayo Clinic in Florida | Jacksonville, Florida, United States | Recruiting |
| University of Miami Hospital and Clinics, Sylvester Cancer Center | Miami, Florida, United States | Recruiting |
| Local Institution - 0053 | Chicago, Illinois, United States | Active Not Recruiting |
| Local Institution - 0030 | Baltimore, Maryland, United States | Withdrawn |
| Local Institution - 0038 | Boston, Massachusetts, United States | Not Yet Recruiting |
| Local Institution - 0046 | Boston, Massachusetts, United States | Withdrawn |
| University of Massachusetts Chan Medical School | Worcester, Massachusetts, United States | Not Yet Recruiting |
| University of Massachusetts Chan Medical School | Worcester, Massachusetts, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
+ 42 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05869955